首页> 外文期刊>Scientific reports. >Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease
【24h】

Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease

机译:血清外泌体MicroRNA套作为川崎病的候选诊断生物标志物

获取原文
           

摘要

Although Kawasaki disease is the main cause of acquired heart disease in children, no diagnostic biomarkers are available. We aimed to identify candidate biomarkers for diagnosing Kawasaki disease using serum exosomal microRNAs (miRNAs). Using frozen serum samples from a biobank, high-throughput microarray technologies, two-stage real-time quantitative PCR, and a self-referencing strategy for data normalization, we narrowed down the list of biomarker candidates to a set of 4 miRNAs. We further validated the diagnostic capabilities of the identified miRNAs (namely, CT(miR-1246)-CT(miR-4436b-5p) and CT(miR-197-3p)-CT(miR-671-5p)) in 79 samples from two hospitals. We found that this 4-miRNA set could distinguish KD patients from other febrile patients as well as from healthy individuals in a single pass, with a minimal rate of false positives and negatives. We thus propose, for the first time, that serum exosomal miRNAs represent candidate diagnostic biomarkers for Kawasaki disease. Additionally, we describe an effective strategy of screening for biomarkers of complex diseases even when little mechanistic knowledge is available.
机译:虽然川崎病是儿童患有心脏病的主要原因,但没有诊断生物标志物。我们旨在识别使用血清外泌体MicroRNA(miRNA)诊断川崎病的候选生物标志物。使用来自BioBank的冷冻血清样本,高通量微阵列技术,两级实时定量PCR和用于数据标准化的自我参考策略,我们将生物标志物候选列表缩小到一组4个miRNA。我们进一步验证了79个样品中鉴定的miRNA(即,CT-1246)-CT(miR-443-5p)和ct(miR-197-3p)-ct(miR-671-5p)的诊断功能)来自两家医院。我们发现,这项4-miRNA集可以将KD患者与其他发热患者的kd患者区分开,从单一通过中的健康个体,具有最小的误报和底片。因此,我们首次提出血清外泌体MiRNA代表川崎病的候选诊断生物标志物。此外,我们甚至可以描述筛查复杂疾病的生物标志物的有效策略,即使在适用于小型机械知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号